|
|
| | H-THR-SER-GLY-PRO-LEU-GLY-ASN-LEU-ALA-GLU-GLU-LEU-ASN-GLY-TYR-SER-ARG-LYS-LYS-GLY-GLY-PHE-SER-PHE-ARG-PHE-NH2 Basic information |
| Product Name: | H-THR-SER-GLY-PRO-LEU-GLY-ASN-LEU-ALA-GLU-GLU-LEU-ASN-GLY-TYR-SER-ARG-LYS-LYS-GLY-GLY-PHE-SER-PHE-ARG-PHE-NH2 | | Synonyms: | H-THR-SER-GLY-PRO-LEU-GLY-ASN-LEU-ALA-GLU-GLU-LEU-ASN-GLY-TYR-SER-ARG-LYS-LYS-GLY-GLY-PHE-SER-PHE-ARG-PHE-NH2;ORPHAN GPCR SP9155 AGONIST P518 (HUMAN);ORPHAN G-PROTEIN COUPLED RECEPTOR SP9155 AGONIST PEPTIDE P518 (HUMAN);P518 (HUMAN);Orphan GPCR SP9155 Agonist P518 (huMan)
P518 (huMan), Orphan G-Protein Coupled Receptor SP9155 Agonist Peptide P518 (huMan);P518 (huMan), Orphan G-Protein Coupled Receptor SP9155 Agonist Peptide P518 (huMan);L-Phenylalaninamide, L-threonyl-L-serylglycyl-L-prolyl-L-leucylglycyl-L-asparaginyl-L-leucyl-L-alanyl-L-α-glutamyl-L-α-glutamyl-L-leucyl-L-asparaginylglycyl-L-tyrosyl-L-seryl-L-arginyl-L-lysyl-L-lysylglycylglycyl-L-phenylalanyl-L-seryl-L-phenylalanyl-L-arginyl-;Human 26RFa | | CAS: | 600171-68-4 | | MF: | C127H195N37O37 | | MW: | 2832.13 | | EINECS: | | | Product Categories: | | | Mol File: | 600171-68-4.mol |  |
| | H-THR-SER-GLY-PRO-LEU-GLY-ASN-LEU-ALA-GLU-GLU-LEU-ASN-GLY-TYR-SER-ARG-LYS-LYS-GLY-GLY-PHE-SER-PHE-ARG-PHE-NH2 Chemical Properties |
| density | 1.48±0.1 g/cm3(Predicted) |
| | H-THR-SER-GLY-PRO-LEU-GLY-ASN-LEU-ALA-GLU-GLU-LEU-ASN-GLY-TYR-SER-ARG-LYS-LYS-GLY-GLY-PHE-SER-PHE-ARG-PHE-NH2 Usage And Synthesis |
| | H-THR-SER-GLY-PRO-LEU-GLY-ASN-LEU-ALA-GLU-GLU-LEU-ASN-GLY-TYR-SER-ARG-LYS-LYS-GLY-GLY-PHE-SER-PHE-ARG-PHE-NH2 Preparation Products And Raw materials |
|